Results of two trials of chemoattenuated PfSPZ vaccines in controlled human malaria infections July 9, 2021
New phase II/III study evaluates BLU-263 in patients with indolent systemic mastocytosis July 9, 2021
Chemoattenuated Pf sporozoite-based vaccine shows efficacy, good tolerance and immunogenicity June 28, 2021
Sanofi Pasteur and Translate Bio begin phase I trial of mRNA seasonal influenza vaccine June 22, 2021
RSS